United States · Series C startup

Who invested in Jnana Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$107Mraised across 1 round since 2022, from 1 source

Latest round
Series C, $107MNov 2022
Investors
5
See who backed them

The rounds

  1. Nov 2022
    Series C$107M

    Source recordedSEC filing: $60M sold, first sale Nov 2022

Founders and team

From Jnana Therapeutics's own website and the SEC filings it signed: 1 founder, 5 on the team.

Scientific CofoundersCofounder and Founding CEO
  • Joanne D. KotzChief Executive Officer, Treasurer, Secretary and Directori
  • George W. VratsanosChief Medical Officer and Head of R&Di
  • James SauerChief Financial Officer
  • Caroline Stark BeerChief Business Officeri
  • Douglas W. PaganChief Financial Officer and Chief Operating Officeri

On the board, as filediAnnie C. ChenBrian M. CaliCarlo W. RizzutoDonald W. NicholsonMatthew W. HammondRonald C. RenaudTerrance G. McGuire

Everyone who backed them

Polaris PartnersVC firm1round
RA Capital ManagementPrivate equity1round
Versant VenturesVC firm1round
AbbVieCorporate VC1round
Bain Capital Life SciencesPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Jnana Therapeutics

Who invested in Jnana Therapeutics?

Jnana Therapeutics's investors include Polaris Partners, RA Capital Management, Versant Ventures, AbbVie and Bain Capital Life Sciences.

How much has Jnana Therapeutics raised?

Jnana Therapeutics has raised $107M across 1 round since 2022.

When did Jnana Therapeutics last raise?

Jnana Therapeutics's most recent round was a Series C of $107M in Nov 2022.

What was Jnana Therapeutics's biggest round?

Its most recent round, $107M in Nov 2022, is also its largest on record.

Who backed Jnana Therapeutics first?

Jnana Therapeutics's first round on record, in Nov 2022, was backed by Polaris Partners, RA Capital Management and Versant Ventures and 2 others.

What stage is Jnana Therapeutics at?

Jnana Therapeutics's latest named round is a Series C, in Nov 2022.

Where is Jnana Therapeutics based?

Jnana Therapeutics is based in the United States.

Companies like Jnana Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.